Size-based fractionation

Show results for

Proteomics (202)
Unknown (175)
Transcriptomics (29)
Genomics (16)
Metabolomics (6)
Other (5)
Multiomics (1)

Organisms

Allexis (186)
Arabidopsis thaliana (186)
Bos taurus (186)
Callinectes sapidus (186)
Drosophila melanogaster (186)
Entamoeba histolytica HM-1:IMSS-A (186)
Escherichia coli (186)
Homo sapiens (186)
Leishmania major strain Friedlin (186)
Listeria monocytogenes (186)
Medicago truncatula (186)
Homo sapiens (10)
Saccharomyces cerevisiae (5)
Schizosaccharomyces pombe (3)
Mus musculus (3)
Caenorhabditis elegans (2)
Drosophila melanogaster (2)
Gallus gallus (2)
Vitis labrusca x Vitis vinifera (1)
Hypophthalmichthys nobilis (1)
Citrus trifoliata (1)
synthetic construct (1)
Zea mays (1)
Rattus rattus (1)
Bos taurus (1)
Canis lupus familiaris (1)
Arabidopsis thaliana (1)
Vibrio campbellii CAIM 519 = NBRC 15631 = ATCC 25920 (1)
Bubalus bubalis (1)
Escherichia coli (1)

Organisms

Saccharomyces cerevisiae (4)
Homo sapiens (2)
Vibrio campbellii CAIM 519 = NBRC 15631 = ATCC 25920 (1)
Mus musculus (1)

Repository

pride (186)
biostudies-arrayexpress (31)
MassIVE (13)
ENA (13)
MetaboLights (4)
geo (2)
GNPS (2)
GPMDB (2)
jPOST (2)
PanoramaPublic (2)
iProX (1)

Tissue

Cell culture (38)
Brain (14)
Epithelial cell (13)
Blood plasma (10)
Heart (10)
Blood serum (9)
Permanent cell line cell (9)
Liver (6)
Kidney (5)
Leaf (5)
Hepatocyte (4)
Plant cell (4)
Skin (4)
Urine (4)
Cerebrospinal fluid (3)
Lung (3)
Primary cell (3)
Blood (2)
Blood cell (2)
Bone marrow (2)
Cardiac muscle cell (2)
Embryonic stem cell (2)
Fibroblast (2)
HeLa cell (2)
Keratinocyte (2)
Lymph node (2)
Macrophage (2)
Ovary (2)
Pluripotent stem cell (2)
T cell (2)

Disease

Breast cancer (6)
Cervix carcinoma (5)
Disease free (3)
Pancreatic cancer (3)
Not Available (2)
Alzheimer's disease (2)
Brain glioblastoma multiforme (2)
Cardiomyopathy (2)
Cardiovascular system disease (2)
Colon cancer (2)
Non-small cell lung carcinoma (2)
Pancreatic ductal adenocarcinoma (2)
Prostate adenocarcinoma (2)
Normal (1)
Acute leukemia (1)
Adult respiratory distress syndrome (1)
Age related macular degeneration (1)
Asthma (1)
Brain cancer (1)
Bronchiolitis obliterans (1)
COVID-19 (1)
Cataract (1)
Chagas disease (1)
Chronic myelomonocytic leukemia (1)
Congenital disorder of glycosylation type I (1)
Duchenne muscular dystrophy (1)
Exfoliation syndrome (1)
Human immunodeficiency virus infectious disease (1)
Merkel cell carcinoma (1)
Parkinson's disease (1)

Technology Type

Mass Spectrometry (186)
Shotgun proteomics (96)
Bottom-up proteomics (37)
SWATH MS (29)
Data-dependent acquisition (24)
Data-independent acquisition (13)
Top-down proteomics (10)
Affinity purification coupled with mass spectrometry proteomics (9)
Gel-based experiment (8)
SRM/MRM (5)
Mass spectrometry (4)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
DiaPASEF (3)
Immunopeptidomics (2)
MSE (1)

Instrument Platform

Impact II (4)
Illumina HiSeq 2000 (2)
Instrument (2)
Orbitrap Fusion Lumos (2)
Q Exactive (2)
Q Exactive HF (2)
Q Exactive Plus (2)
Liquid Chromatography MS - negative - reverse phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Axon GenePix 4000B scanning hardware (1)
Illumina MiSeq (1)
Illumina HiSeq 1500 (1)
LTQ Orbitrap Velos (1)
MaXis (1)
NHMFL 21T FT-ICR-MS (1)
TripleTOF 5600 (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)

Publication Date

2025 (32)
2022 (31)
2024 (23)
2021 (22)
2026 (21)
2023 (18)
2019 (17)
2018 (13)
2020 (13)
2015 (10)
2017 (10)
2016 (7)
2010 (7)
2013 (4)
2014 (3)
2012 (3)
2009 (2)
2006 (2)
2011 (1)
2008 (1)
2007 (1)

CHEBI ID

CHEBI:53013 (2)
CHEBI:17256 (2)
CHEBI:18186 (2)
CHEBI:15956 (2)
CHEBI:25017 (2)
CHEBI:16831 (2)
CHEBI:16704 (2)
CHEBI:17621 (2)
CHEBI:17310 (2)
CHEBI:17713 (2)
CHEBI:16113 (2)
CHEBI:16695 (2)
CHEBI:16750 (2)
CHEBI:17345 (2)
CHEBI:15940 (2)
CHEBI:17154 (2)
CHEBI:16335 (2)
CHEBI:17596 (2)
CHEBI:17368 (2)
CHEBI:86181, CHEBI:86137 (1)
CHEBI:86129, CHEBI:42027 (1)
CHEBI:85076, CHEBI:84234 (1)
CHEBI:83122 (1)
CHEBI:82724, CHEBI:83413 (1)
CHEBI:78268, CHEBI:79110 (1)
CHEBI:76325 (1)
CHEBI:76302, CHEBI:84746 (1)
CHEBI:75610, CHEBI:75577 (1)
CHEBI:74986, CHEBI:84839 (1)
CHEBI:74964 (1)

Metabolite Name

Skatol (1)
Simvastatin lactone (1)
Phosphatidylcholine(18:0/18:1w9) (1)
GPCho(34:0) (1)
GPCho(18:3n3/18:3n3) (1)
GPCho(18:2w6/18:2w6) (1)
N-Stearoylethanolamide (1)
12-Hydroxy-Octadecanoic Acid (1)
L-Hexanoic acid ester with (3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt (1)
(Z)-N-[(E,2S,3R)-1,3-bis(oxidanyl)octadec-4-en-2-yl]docos-13-enamide (1)
(3R)-3-[(Z)-octadec-9-enoyl]oxy-4-(trimethylazaniumyl)butanoate (1)
(-)-Tetradecanoylcarnitine (1)
L-gamma-glutamyl-l-alpha-aminobutyrylglycine (1)
N-(1,5-dimethyl-3-oxidanylidene-2-phenyl-pyrazol-4-yl)methanamide (1)
C18 Sphingomyelin (1)
OSF (1)
N-L-gamma-Glutamyl-L-tyrosine (1)
2-amino-5-[(1-carboxy-2-phenyl-ethyl)amino]-5-keto-valeric acid (1)
DAG(32:0) (1)
(2S)-3-(5-mercapto-3-methyl-imidazol-4-yl)-2-(methylammonio)propionate (1)
NODULARIN (1)
Phosphatidylserine(38:4) (1)
Phosphatidylserine(36:1) (1)
C16 sphingomyelin (1)
PE(18:0/20:4w6) (1)
Elthon (1)
(R)-Dodecanoylcarnitine (1)
22:0(2R-OH) (1)
26-oxidanylhexacosanoic acid (1)
1-Nitroso-Piperidine (1)

First Public Date

2013 (4)
2022 (2)
2014 (2)
2025 (1)
2020 (1)
2019 (1)
2018 (1)
2015 (1)

Classification

bacteria (1)

Study type

RNA-seq of non coding RNA (10)
RNA-seq of coding RNA (5)
Other (4)
Transcription profiling by array (4)
ChIP-seq (3)
Unknown experiment type (1)
Translation profiling (1)
ChIP-chip by array (1)
MicroRNA profiling by high throughput sequencing (1)
Comparative genomic hybridization by array (1)

Release Date

2025 (25)
2022 (23)
2023 (17)
2021 (17)
2018 (16)
2024 (14)
2020 (13)
2019 (12)
2017 (11)
2015 (10)
2010 (10)
2016 (8)
2014 (6)
2013 (6)
2012 (4)
2026 (4)
2011 (2)
2009 (2)
2007 (2)
2006 (2)
2008 (1)
2002 (1)

Lab affiliation

Michigan State University (4)
Center of Human and Molecular Biology (ZHMB), Saarland University School of Medicine, Homburg, Germany (3)
Institut für Mikrobiologie, Universität Greifswald, Felix-Hausdorff-Str. 8, 17489 Greifswald (3)
Department of Biochemistry and Molecular Biology and the Biomedicine Discovery Institute; Monash University; Clayton 3800; Victoria; Australia (2)
Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. The Center for Functional Proteomics, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany. Frankfurt Cancer Institute, Frankfurt am Main, Germany. Cardio-Pulmonary Institute, Frankfurt am Main, Germany. (2)
Max-Planck-Institut für Molekulare Pflanzenphysiologie (2)
Plant Physiology Group Westfälische WIlhelms-Universität Münster Germany (2)
1 Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany 2 German Cancer Consortium (DKTK), Partner-site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany 3 Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), Technical University of Munich (TUM), Freising, Germany (1)
1 Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Auguste-Piccard-Hof 1, 8093 Zurich, Switzerland 2 Faculty of Science, University of Zurich, Zurich, Switzerland (1)
1Department of Chemistry, Michigan State University, 578 S Shaw Lane, East Lansing, Michigan 48824, USA (1)
5Faculty of Biology, Technion-Israel Institute of Technology, Haifa-3200003, Israel. (1)
Assistant Professor of Medicine Department of Medicine Tulane University School of Medicine 1430 Tulane Avenue, New Orleans, LA,70114 (1)
Associate Professor, University of Nevada, Reno department of Pharmacology (1)
Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland (1)
Australian Proteome Analysis Facility, Macquarie University, NSW 2109, Australia (1)
BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University (1)
Bioanalytics, Institute of Biotechnology, Technische Universität Berlin, 13355 Berlin, Germany (1)
Biomolecular Mass Spectrometry and Proteomics,Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Padualaan 8, Utrecht 3584 CH, The Netherlands Netherlands Proteomics Center, Padualaan 8, Utrecht 3584 CH, the Netherlands (1)
Biosciences and Nutrition, Riedel Lab, Karolinska Institute, Sweden (1)
CIR, Queen’s Medical Research Institute, University of Edinburgh (1)
Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK. (1)
Cell Signaling and Immunology, School of Life Science, University of Dundee, Dundee. United Kingdom (1)
Central Diagnostic Laboratory Maastricht University Medical Centre Maastricht, the Netherlands (1)
Centre for Animal Science Queensland Alliance for Agriculture and Food Innovation, University of Queensland, Australia (1)
Centre for Animal Science, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Australia (1)
Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia (1)
Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Australia. Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Australia. 2 Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Australia. 3 Monash Proteomics and Metabolomics Platform, Clinical Proteomics Node, School of Clinical Sciences, Monash University, Clayton, Australia (1)
Charles University, Faculty of Science, Department of Parasitology, BIOCEV, Vestec 252 50, Czech Republic. (1)
Chronic Disease Programme, UFIEC, Instituto de Salud Carlos III, 28220 Majadahonda, Madrid, Spain. (1)
Clinical Chemistry, Department of Translational Medicine, Lund University, Skane University Hospital Malmö, 205 02 Malmö, Sweden. (1)

Previous page
1 / 44
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 44
Next page

Sort by:

Relevance

Page size

Integrating two chromatographies in a co-fractionation mass spectrometry approach improved protein-metabolite interactions (PMIs) mapping capabilities and revealed novel protein-ligand pairings in Escherichia coli.

The protein-metabolite interactome remains understudied. We previously developed a co-fractionation mass-spectrometry-based approach called PROMIS to address this gap. PROMIS relies on size separation chromatography of protein-metabolite complexes from lysates, followed by proteomics and metabolomic...

2025-04-25 | MTBLS9098 | MetaboLights

Comparison of fractionation proteomics for local SWATH library building

For data-independent acquisition by means of sequential window acquisition of all theoretical fragment ion spectra (SWATH), a reference library of data-dependent acquisition (DDA) runs is typically used to correlate the quantitative data from the fragment ion spectra with peptide identifications. Th...

ORGANISM(S): Homo sapiens (Human)

2017-07-04 | PXD006190 | Pride

Genomewide demarcation of RNA PolII transcription units by physical fractionation of chromatin- ORF-INT enrichment

Epigenetic modifications of chromatin serve an important role in regulating the expression and accessibility of genomic DNA. We report here a genomewide approach for fractionating yeast chromatin into two functionally distinct parts, one containing RNA polymerase II transcribed sequences, and the ot...

ORGANISM(S): Saccharomyces cerevisiae

2006-08-30 | E-GEOD-5650 | biostudies-arrayexpress

Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics.

Proteins form a diverse array of complexes that mediate cellular function and regulation. A largely unexplored feature of such protein complexes is the selective participation of specific protein isoforms and/or post-translationally modified forms. In this study, we combined native size-exclusion ch...

ORGANISM(S): Homo sapiens (Human)

2014-08-14 | PXD001220 | Pride

U2os cells Human

Reverse-phase liquid chromatography (RPLC) in Combination with Tip-Based Strong Cation Exchange (SCX-Tip) Fractionation, ReST, an Alternative Approach for Cross-linked Peptides analysis

Chemical cross-linking in combination with mass spectrometry (XL-MS) has emerged as a useful method for structural elucidation of proteins and protein complexes. Efficient enrichment procedures are necessary to analyze cross-linked products due to their relatively low abundance. Currently, strong ca...

ORGANISM(S): Homo sapiens (Human)

2022-06-16 | PXD023817 | Pride

Scx-tip Mass spectrometry Fractionation Chemical cross-linking

Genomewide demarcation of RNA PolII transcription units by physical fractionation of chromatin- ALL Arrays

ORGANISM(S): Saccharomyces cerevisiae

2006-08-30 | E-GEOD-5662 | biostudies-arrayexpress

Total organic carbon (TOC): a simple tool for assessing micro(nano)plastics and nanocellulose recovery during size-based fractionation.

Not available

S-EPMC12103321 | biostudies-literature

Genomewide demarcation of RNA PolII transcription units by physical fractionation of chromatin- Intergenic enrichment

ORGANISM(S): Saccharomyces cerevisiae

2010-07-01 | E-GEOD-5648 | biostudies-arrayexpress